The first chief patient officer role was created in 2014, and since then, biopharmaceutical companies have created similar positions, restructured teams, and convened internal meetings to advance patient engagement and patient-centered practices throughout their organizations. Similarly, disease foundations that fund research to improve the lives of their patient community discovered that they, too, could benefit from being more internally focused as organizations on connecting directly with their patient community. In the world of value-based care, hospitals are also realigning the processes to ensure that patients are part of the input around what value the care is providing. The panel will highlight ways organizations are restructuring and realigning themselves to ensure they are providing the best possible patient care.

Moderator

Susan Schaeffer
President and CEO, The Patients' Academy for Research Advocacy; Former Editor of BioCentury

Speakers

Julie Gerberding
Executive Vice President and Chief Patient Officer, Merck

Ivor Horn
Chief Medical Officer, Accolade

Kathy Hudson
CEO, People-Centered Research Foundation

Bray Patrick-Lake
Director, Stakeholder Engagement, Duke Clinical Research Institute; Senior Fellow, FasterCures

Janet Woodcock
Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration